Overall Survival and Progression-Free Survival of Patients Following Luspatercept Treatment in the MEDALIST Trial

被引：2
|
作者：
Santini, Valeria [1 ]
Fenaux, Pierre [2 ]
Zeidan, Amer M. [3 ,4 ]
Komrokji, Rami S. [5 ]
Buckstein, Rena [6 ]
Oliva, Esther Natalie [7 ]
Ha, Xianwei [8 ]
Miteva, Dimana [9 ]
Yucel, Aylin [8 ]
Nadal, Jose Alberto [9 ]
Platzbecker, Uwe [10 ]
机构：
[1] Univ Florence, Florence, Italy
[2] Hop St Louis, Assistance Publ Hop Paris AP HP, Paris, France
[3] Yale Univ, Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Yale Canc Ctr, New Haven, CT USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[7] Grande Osped Metropolitano Bianchi Melacrino More, Reggio Di Calabria, Italy
[8] Bristol Myers Squibb, Princeton, NJ USA
[9] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
[10] Univ Leipzig, Med Ctr, Dept Hematol Cell Therapy & Hemostaseol, Leipzig, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157489
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4079 / 4081
页数：3
相关论文
共 50 条
  • [41] Improved estimation of overall survival and progression-free survival for state transition modeling
    Wigfield, Peter C.
    Heeg, Bart
    Ouwens, Mario
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (01)
  • [42] Effect of total treatment time on progression-free and overall survival in cervix carcinoma
    Delaloye, JF
    Coucke, PA
    Pampallona, S
    DeGrandi, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1172 - 1172
  • [43] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
    Petrelli, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
  • [44] Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas
    Sagberg, Lisa Millgard
    Salvesen, Oyvind
    Jakola, Asgeir Store
    Thurin, Erik
    de Dios, Eddie
    Nawabi, Noah L. A.
    Kilgallon, John L.
    Bernstock, Joshua D.
    Kavouridis, Vasileios K.
    Smith, Timothy R.
    Solheim, Ole
    ACTA ONCOLOGICA, 2024, 63 : 798 - 804
  • [45] A trial-level correlation analysis of progression-free survival as a surrogate for overall survival in the immunotherapy era.
    Yekeduz, Emre
    Koksoy, Elif Berna
    Akbulut, Hakan
    Utkan, Gungor
    Urun, Yuksel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates
    Lipton, Allan
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) : 749 - 762
  • [47] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [48] Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
    Li, Jiayi
    Cao, Dongyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [50] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Hyeong-Seok Lim
    Wan Sun
    Kourosh Parivar
    Diane Wang
    The AAPS Journal, 21
12345